Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013
Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013
Not yet recruiting · NCT07499908 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013 | Healthy Adult | Not yet recruiting | Phase 1 | 2026-04-13 | NCT07499908 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Citryll BV | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ICON | Groningen | Netherlands | 1 |